Linköping – October 12, 2026 -- UK digital pathology provider Diagnexia has signed an annual, renewable agreement with Sectra (STO: SECT B) covering up to 100,000 cases in the first year, enabling it to receive, send and report pathology cases digitally for NHS organisations.

The contract was signed in the second quarter of Sectra's 2026/2027 fiscal year. It uses Sectra's service for advanced share and collaborate workflows to connect Diagnexia with NHS bodies that need external specialist support.